Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 2 pages · Chinese
Release
Henan Lingrui Pharmaceutial Co., Ltd. on 6ix
Earlier from Henan Lingrui Pharmaceutial
- Announcement on Election of Employee Representative Directors for the 10th Board of Directors
- Announcement on the Release of Pledge of Partial Shares by Major Shareholders
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on the Pledge of Partial Shares by the Majority Shareholders
Later from Henan Lingrui Pharmaceutial
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Resolutions of the 2nd Meeting of the 10th Board of Directors
- Announcement on Obtaining Notice of Approval for Drug Supplementary Application
- Announcement on Inclusion of Products of the Company and Its Subsidiaries in the "National Essential Medicines List (2026 Edition)"
- Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major Shareholder
Follow Henan Lingrui Pharmaceutial into a list and get an email when it puts out news.
Follow Henan Lingrui Pharmaceutial